BioNTech/ Genmab post early data for lung cancer therapy (NASDAQ:BNTX)
koto_feja BioNTech (NASDAQ:BNTX) and Genmab (GMAB) introduced Saturday that their investigational bispecific antibody acasunlimab improved survival charges amongst lung most ...
Tag: NASDAQBNTX
